TR201905806T4 - Diklofenak bileşimi. - Google Patents

Diklofenak bileşimi. Download PDF

Info

Publication number
TR201905806T4
TR201905806T4 TR2019/05806T TR201905806T TR201905806T4 TR 201905806 T4 TR201905806 T4 TR 201905806T4 TR 2019/05806 T TR2019/05806 T TR 2019/05806T TR 201905806 T TR201905806 T TR 201905806T TR 201905806 T4 TR201905806 T4 TR 201905806T4
Authority
TR
Turkey
Prior art keywords
diclofenac
composition
salts
present
diclofenac composition
Prior art date
Application number
TR2019/05806T
Other languages
English (en)
Inventor
Shantilal Patel Dinesh
Dinesh Patel Shachin
Prabhudas Kurani Shashikant
Govindlal Patel Madhavlal
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201905806(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Publication of TR201905806T4 publication Critical patent/TR201905806T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, Diklofenak ve bunun tuzlarını içeren bir bileşim ile ilgilidir, burada Diklofenak veya bunun tuzları, 25 -200 mg miktarında mevcuttur. Bileşim, intramüsküler, intravenöz yol aracılığıyla parenteral uygulamaya; ve aynı zamanda oral, dermal, subkütanöz, kütanöz, nazal, oküler damlalara yönelik, rektal supozituvar, vajinal pesserler, intra-artiküler ve otik dağıtım olarak uygundur. Buluş aynı zamanda, Diklofenak ve diğer ilaçların bir kombinasyonunu içeren bileşimler sağlar. Buluş ayrıca, söz konusu bileşimin hazırlanmasına yönelik bir yöntem sağlar.
TR2019/05806T 2012-12-28 2013-12-27 Diklofenak bileşimi. TR201905806T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28

Publications (1)

Publication Number Publication Date
TR201905806T4 true TR201905806T4 (tr) 2019-05-21

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/05806T TR201905806T4 (tr) 2012-12-28 2013-12-27 Diklofenak bileşimi.

Country Status (25)

Country Link
US (1) US20140187635A1 (tr)
EP (1) EP2938325B8 (tr)
JP (1) JP6117939B2 (tr)
KR (1) KR101730284B1 (tr)
CN (1) CN104968331A (tr)
AP (1) AP2015008534A0 (tr)
AU (1) AU2013368849B2 (tr)
BR (1) BR112015015699B1 (tr)
CL (1) CL2015001869A1 (tr)
EA (1) EA035079B1 (tr)
ES (1) ES2721400T3 (tr)
HK (1) HK1211858A1 (tr)
HU (1) HUE045030T2 (tr)
IL (1) IL239395A0 (tr)
MA (1) MA38292A1 (tr)
MX (1) MX365375B (tr)
MY (1) MY184886A (tr)
PE (1) PE20151208A1 (tr)
PH (1) PH12015501479B1 (tr)
SG (1) SG11201504577UA (tr)
SI (1) SI2938325T1 (tr)
TR (1) TR201905806T4 (tr)
UA (1) UA114123C2 (tr)
WO (1) WO2014102824A1 (tr)
ZA (1) ZA201504258B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
SG11202103374TA (en) * 2018-11-16 2021-05-28 Seikagaku Kogyo Co Ltd Pharmaceutical composition
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
US12246024B2 (en) * 2019-12-13 2025-03-11 Free State Pharma Inc Compositions and methods for controlling cerumen production
IL294521A (en) * 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
AU662160B2 (en) * 1991-07-04 1995-08-24 Taisho Pharmaceutical Co., Ltd. Analgesic
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20050203000A1 (en) * 2003-03-26 2005-09-15 Sutter Diane E. Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
DE602004025151D1 (de) 2004-03-10 2010-03-04 Shimoda Biotech Pty Ltd Stabile injizierbare Diclofenac- Zubereitungen
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
EA013616B1 (ru) * 2005-02-01 2010-06-30 Троикаа Фармасьютикалз Лтд. Инъекционные препараты диклофенака и его фармацевтически приемлемых солей
BRPI0611170A2 (pt) * 2005-05-27 2010-08-17 Panacea Biotec Ltd composições injetáveis e processo para o preparo de tais composições
BRPI0921654A2 (pt) 2008-11-28 2016-02-10 Advance Holdings Ltd formulação farmacêutica

Also Published As

Publication number Publication date
US20140187635A1 (en) 2014-07-03
MA38292A1 (fr) 2017-06-30
WO2014102824A8 (en) 2014-10-02
BR112015015699A2 (pt) 2017-07-11
WO2014102824A1 (en) 2014-07-03
HUE045030T2 (hu) 2019-12-30
ES2721400T8 (es) 2019-10-10
MY184886A (en) 2021-04-29
PH12015501479B1 (en) 2019-11-15
BR112015015699B1 (pt) 2022-09-27
EA035079B1 (ru) 2020-04-24
PE20151208A1 (es) 2015-08-23
KR101730284B1 (ko) 2017-04-25
JP2016508139A (ja) 2016-03-17
AU2013368849A1 (en) 2015-07-09
AP2015008534A0 (en) 2015-06-30
SG11201504577UA (en) 2015-07-30
AU2013368849B2 (en) 2017-01-12
MX2015008369A (es) 2016-03-01
PH12015501479A1 (en) 2015-09-21
SI2938325T1 (sl) 2019-06-28
KR20150090250A (ko) 2015-08-05
ZA201504258B (en) 2016-04-28
MX365375B (es) 2019-05-31
JP6117939B2 (ja) 2017-04-19
HK1211858A1 (en) 2016-06-03
EP2938325B8 (en) 2019-09-25
CN104968331A (zh) 2015-10-07
EP2938325B1 (en) 2019-04-10
ES2721400T3 (es) 2019-07-31
UA114123C2 (xx) 2017-04-25
EP2938325A1 (en) 2015-11-04
CL2015001869A1 (es) 2015-10-23
EA201591230A1 (ru) 2015-11-30
IL239395A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
PH12015501479B1 (en) Diclofenac composition
MX2020008468A (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
MX392126B (es) Sistemas de deposito que comprende glatiramer o una sal farmacologicamente aceptable del mismo
PE20141171A1 (es) Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide
CY1116143T1 (el) Παραγωγα χρωμενονης με αντικαρκινικη δραση
NZ709958A (en) Enhanced stability of novel liquid compositions
EA201792652A3 (ru) Новые производные майтанзиноида с пептидным линкером и их конъюгаты
PH12015501083B1 (en) Novel pyridine derivatives
MY182229A (en) Use of an alkoxylated polytetrahydrofuran as an additive in a fuel
MX2020014208A (es) Agentes terapeuticos para administracion subcutanea optimizados.
BR112014002173A2 (pt) proteínas purificadas
MX361642B (es) Composiciones antisépticas catiónicas.
BR112014003096A2 (pt) uso de ccne2 como marcador de estratificação no tratamento de tumores de mama com inibidores de pan-cdk
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX342511B (es) Metodos y composiciones para tratar la enfermedad de raynaud.
BR112014012849A2 (pt) derivados de espirotienopirano-piperidina como antagonistas do receptor de orl-1 para seu uso no tratamento de dependência e abuso de álcool
UY34154A (es) Dosificación y administración de anticuerpos anti-erbb3 en combinación con paclitaxel.
BR112013024196A2 (pt) complexos de gálio, composições farmacêuticas e métodos de uso
BR112014018426A8 (pt) Composição e dispositivo para administração transdérmica, e, método para administrar uma progestina
PL399298A1 (pl) Kompozycja farmaceutyczna do stosowania miejscowego zawierajaca acyklowir oraz sposób jej wytwarzania
BR112013023599A2 (pt) método para preparar um conjugado de carboidrato-epítopo de célula-t, conjugado de carboidrato-epítopo de célula-t, e, uso de um conjugado de carboidrato-epítopo de célula-t
WO2014039787A3 (en) Germanium-containing camptothecin analogues
RU2009134545A (ru) Способ повышения противоопухолевой резистентности
BR112014003100A2 (pt) emprego de mad2l2 como um marcador de estratificação no tratamento de tumores de mama com novos inibidores pan-cdk
ECSP15000500A (es) Solucion de acetaminofen supersaturada inyectable para la administracion por la espina dorsal